New Approaches for Improving Transplant Outcomes in ALL Patients with MRD
New Approaches for Improving Transplant Outcomes in ALL Patients with MRD
Track: BMT Tandem "Scientific" Meeting
Thursday, February 27, 2014, 12:30 PM-1:30 PM
Texas B+D (Gaylord Texan)
Disclosures:
M. R. Litzow,
Talon Therapeutics, Amgen: Consulting Fees
Sigma-Tau: Fees for Non-CME Services received directly from Commercial Interest or their Agents
Amgen: Contracted Research
Sigma-Tau: Fees for Non-CME Services received directly from Commercial Interest or their Agents
Amgen: Contracted Research
See more of: BMT Tandem Luncheon Symposium: Current Status of Stem Cell Transplantation for Acute Lymphoblastic Leukemia
See more of: BMT Tandem "Scientific" Meeting
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation
|
Next Presentation